Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Am Geriatr Soc. 2017 Feb 2;65(6):1183–1189. doi: 10.1111/jgs.14759

Table 2.

CNS Medication Standardized Daily Dose by Class and Overall by Group Status, Within 6 Days Prior To the Outcome

CNS Class and Overall SDD Variables Controls
(n=1468)
Mean (sd)
[IQR]
Cases
(N=367)
Mean (sd)
[IQR]
P value*
Antidepressants (SSRIs or SNRIs or TCAs) 0.76 (1.34)
[0.0–1.0]
1.07 (1.55)
[0.0–2.0]
<0.001
Antiepileptics 0.18 (0.55)
[0–0]
0.24 (0.72)
[0–0]
0.05
Antipsychotics 0.47 (2.38)
[0–0]
0.83 (2.95)
[0–0]
0.02
Benzodiazepine receptor agonist hypnotics 0.08 (0.34)
[0–0]
0.06 (0.32)
[0–0]
0.37
Opioids receptor agonists 0.97 (2.56)
[0–0]
0.88 (1.96)
[0–0.65]
0.54
Overall CNS Medication Use 2.45 (4.01)
[0–3.2]
3.07 (4.29)
[0–4.3]
0.008
CNS SDD Use Categories, n (%) <0.001
 0 520 (35.4) 114 (31.1)
 >0 – <3 537 (36.6) 102 (27.8)
 3+ 411 (28.0) 151 (41.1)

Abbreviations: CNS = central nervous system; IQR= inter quartile range (25th–75th percentile); SD= standard deviation; SNRI = serotonin norepinephrine reuptake inhibitor; SSRI = selective serotonin reuptake inhibitor; SDD=standardized daily dose; TCA = tricyclic antidepressant